Congratulations to Geulah Livshits, PhD, Senior Research Analyst for ranking in TipRanks' top 10 health care sector analysts of the past decade! cnbc.com/2023/05/21/tip…

Chardan is pleased to act as Financial Advisor for Presto's $10 million PIPE. Presto (Nasdaq: PRST) provides enterprise-grade AI solutions to some of the nation’s largest hospitality brands. Read more about the transaction here: globenewswire.com/news-release/2… #ChardanTransactions

Chardan’s Viral News in Genetic Medicines is a weekly piece that details key news and industry research in the #GeneticMedicines space. To learn more about Viral News in Genetic Medicines and Chardan research, please email [email protected] #genetherapy #geneediting #celltherapy

Chardan’s Viral News in Genetic Medicines is a weekly piece that details key news and industry research in the #GeneticMedicines space. To learn more about Viral News in Genetic Medicines and Chardan research, please email [email protected] #genetherapy #geneediting #celltherapy

Chardan’s Viral News in Genetic Medicines is a weekly piece that details key news and industry research in the #GeneticMedicines space. To learn more about Viral News in Genetic Medicines and Chardan research, please email [email protected] #genetherapy #geneediting #celltherapy

Chardan’s Viral News in Genetic Medicines is a weekly piece that details key news and industry research in the #GeneticMedicines space. To learn more about Viral News in Genetic Medicines and Chardan research, please email [email protected] #genetherapy #geneediting #celltherapy

Chardan is recruiting for our 2024 Banking Summer #Internship Program! We are accepting applications from students graduating in winter 2024 or spring 2025. Deadline to apply is 8/1/2023. Visit chardan.com/careers for more info & email resumes to [email protected] to apply.

Chardan has initiated coverage of 4D Molecular Therapeutics (FDMT) with a Buy rating and 12 month price target of $30, on the potential of its directed evolution AAV platform to tackle historic obstacles to in vivo gene delivery. #ChardanResearch #Biotech